BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2005
View Archived Issues
Promising preclinical results reported for novel p38alpha MAP kinase inhibitors
Read More
Highly selective Cdk4/6 inhibitor discovered
Read More
Cytokinetics selects cardiac myosin activator for development candidate
Read More
Diffusion and NABTT sign agreement for TSC clinical trials
Read More
CMC Biopharmaceuticals to produce BSSL for Arexis studies
Read More
STELLAR 3 results for Xyotax in NSCLC
Read More
ViroLogic and AstraZeneca plan Iressa biomarker study
Read More
New preclinical and clinical data available for rotigotine in Parkinson's disease
Read More
Studies reveal safety and treatment benefits of rasagiline in Parkinson's disease
Read More
Mechanisms of CP-690550 evoked immunosuppression
Read More
Interaction of estrogen and epidermal growth factor receptors in the etiology of lung cancer
Read More
Cytyc completes Proxima Therapeutics acquisition
Read More
IP-751 effective in animal model of interstitial cystitis
Read More
New phase III trial studies BAY 43-9006 for advanced liver cancer
Read More
ED-71 promotes bone formation and blocks bone resorption in mice
Read More
Esculetin prodrug protects against disc degeneration in rabbits
Read More
2MD shows promise as an anabolic agent for the treatment of inadequate bone formation
Read More
Telavancin exerts its antibacterial actions via multifunctional mechanisms
Read More
Enrollment open in phase Ib/IIa study of INO-1001 for glioblastoma multiforme
Read More
Labopharm seeks Mexican approval for once-daily tramadol
Read More
deCODE opens phase I study for DG-041 for atherosclerosis
Read More
Enrollment completed in phase II HIV study of TNX-355
Read More
AVE-0010 completes phase IIa study in type 2 diabetes
Read More
Yamanouchi may terminate PYM-50028 licensing agreement with Phytopharm
Read More
Novel cannabinoid receptor modulators prepared at the University of Tennessee
Read More
GSK reports the discovery of new ROCK/Aurora kinase inhibitors
Read More
Two series of glucosylceramide synthase inhibitors claimed by Oxford GlycoSciences
Read More
GSK discloses three series of Gly-T1 transporter inhibitors for schizophrenia
Read More
Two series of novel serine protease inhibitors described by Genentech scientists
Read More
FDA issues public health advisory for Elidel and Protopic
Read More